News & Events about Nanostring Technologies Inc.
Latest Ratings for NSTG
DateFirmActionFromTo Mar 2022JP MorganMaintainsOverweight May 2021Morgan StanleyMaintainsEqual-Weight Mar 2021Morgan StanleyMaintainsEqual-Weight
View More Analyst Ratings for NSTG
View the Latest Analyst Ratings
read more...
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the fourth quarter and fiscal year ended December 31, 2022. NanoString continued to build on our strong...
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the companys management is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference. Brad Gray, president and chief executive...
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that the companys CosMx Spatial Molecular Imager (SI) has been recognized by The Scientist magazine as one of the Top 10 Innovations of the 2022...
Ticker Report
7 months ago
NanoString Technologies, Inc. (NASDAQ:NSTG Get Rating) Director Elisha W. Finney sold 1,945 shares of the businesss stock in a transaction on Friday, June 17th. The shares were sold at an average price of $12.41, for a total transaction of $24,137.45. Following the completion of the ...